We are seeking an internationally recognised scientific leader to direct the Wellcome Sanger Institute’s Somatic Genomics Programme, one of our flagship research domains. This role offers the opportunity to define and deliver a bold, long-term scientific vision for understanding how somatic mutations arise, accumulate and shape human health across the lifespan.

Sanger’s science is organised into a small number of major Programmes, each led by a Head of Programme with significant autonomy. Heads of Programme shape scientific direction, enable delivery through leadership and collaboration, and work within a distinctive non-tenure faculty model that allows scientific leadership to evolve over time. This is a leadership role focused on vision, people and impact, supported by world-class technical, operational and informatics teams.

This appointment provides a rare opportunity to establish a transformative research agenda spanning the origins of cancer and non-neoplastic disease, ageing and mutational processes, leveraging Sanger’s unparalleled scale, technologies and collaborative environment.

About the Programme:

The Somatic Genomics Programme aims to understand the causes and consequences of somatic mutations and epimutations, and their roles in health and disease. The Programme seeks to decipher fundamental processes of mutation, selection and clonal dynamics, and how these might be harnessed for prevention and therapeutic benefit.

Building on Sanger’s world-leading contributions, the Programme will define a 10–15 year research trajectory across cancer and beyond oncology, with scope for significant technology development and broader impact across medicine and biology.